Filing Details
- Accession Number:
- 0001437749-23-034041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-08 19:38:33
- Reporting Period:
- 2023-12-06
- Accepted Time:
- 2023-12-08 19:38:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1625101 | Pulse Biosciences Inc. | PLSE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1055919 | W Robert Duggan | 3957 Point Eden Way Hayward CA 94545 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-06 | 9,933 | $5.95 | 36,601,741 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-12-06 | 82,813 | $9.06 | 36,684,554 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-12-06 | 9,933 | $0.00 | 9,933 | $5.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2033-05-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 351,565 | Indirect | See footnote |
| Common Stock | 492,069 | Indirect | See footnote |
Footnotes
- Volume-weighted average price.
- Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
- Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
- Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a quarterly basis following the Company's 2023 Annual Stockholder Meeting.
Billionaire Hedge Funds
